Compare Danaos Corporation (DAC) vs Definium Therapeutics Inc. Common Shares (DFTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaos Corporation vs Definium Therapeutics Inc. Common Shares — how do they compare? Danaos Corporation trades at $170.2 (market cap $2.99B), while Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B). The key difference: Definium Therapeutics Inc. Common Shares is the larger of the two by market cap, and Danaos Corporation pays a 2.43% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaos Corporation for 25 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| DAC | DFTX | |
|---|---|---|
Market Cap | $2.99B | $4.71B |
Volume | 328,260 | 1,966,636 |
Sector | Industrials | Health |
52-Week High | $170.22 | $48.45 |
52-Week Low | $84.05 | $10.68 |
Typical Hold Time | 25 Days | 0 Days |
Enterprise Value | $2.97B | $3.67B |
Dividend Yield | 2.43% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaos Corporation (DAC) trades at $164.48, down 0.88% on the day, with strong fundamental metrics including a low P/E of 5.57 and robust profitability margins. The stock shows a bullish technical trend, trading above key moving averages, with recent earnings consistently beating expectations. The company maintains strong cash flow generation and has declared multiple dividends, reflecting financial health and shareholder returns.
The outlook remains positive given DAC's undervaluation, earnings momentum, and dividend payments. Key risks include shipping industry cyclicality and global trade volatility. Analyst consensus is evenly split between Buy and Hold, indicating cautious optimism amid strong fundamentals and technical strength.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →
